Keyphrases
Bartonellosis
100%
Bartonella Bacilliformis
100%
Peru
60%
Lima
58%
Minimum Threshold
50%
Cellularity
50%
Umbilical Cord Blood
50%
Bioassay Test
50%
Mountain Valley
50%
Depressive Symptoms
50%
Peruvian
50%
Prospective Cohort Study
50%
Epidemiology
50%
Serodiagnosis
50%
Test Development
50%
Chronic Back Pain
50%
Antibody Assay
50%
Indirect Fluorescent Antibody Test
50%
Cord Blood Unit
33%
Infection Rate
26%
Pain Level
18%
Umbilical Cord Blood Banks
16%
Bacteremia
16%
Illness
16%
Population-based
16%
Clinical Presentation
16%
Vector Control
16%
Hospital Surveillance
16%
Vector Surveillance
16%
Surveillance Task
16%
High Endemicity
16%
Best Predictor
16%
Effective Control
16%
Family Members
16%
Subclinical Infection
16%
Cell Count
16%
Surveillance Methods
16%
5-year-old
16%
Increasing Age
16%
Control Effort
16%
Control Strategy
16%
Blood Samples
10%
Point Prevalence Survey
10%
Andes Mountains
10%
Antibody Detection
10%
Life-threatening
10%
Positive Predictive Value
10%
Serological Test
10%
Acute Phase
10%
Convalescent Phase
10%
Indirect Immunofluorescence Assay
10%
Emerging Infectious Diseases
10%
Laboratory Confirmation
10%
South America
10%
Nucleated Cells
8%
Salud
8%
Total Count
8%
CD34+
8%
Cell Viability
8%
NetCord
8%
Hematologic Tests
8%
Cryopreserved
8%
Flow Cytometry
8%
Female Sex
6%
Marital Status
6%
Education Level
6%
Lumbar
6%
Minimum Level
6%
Beck Depression inventory-II (BDI-II)
6%
Severe Symptoms
6%
Time Duration
6%
Visual Analog Scale
6%
Medicine and Dentistry
Bartonellosis
100%
Endemic Disease
66%
Bartonella bacilliformis
60%
Prospective Cohort Study
50%
Carrion Disease
50%
Wassermann Test
50%
Immunoassay
50%
Cohort Effect
50%
Infection
43%
Household
33%
Disease
26%
Subclinical Infection
16%
Bacteremia
16%
Vector Control
16%
Health Care Cost
16%
Prevalence
10%
Fluorescent Antibody Technique
10%
Emerging Infectious Disease
10%